Related by context. All words. (Click for frequent words.) 69 oral prodrug 68 eniluracil 68 PDE4 inhibitor 68 Bezielle 67 tezampanel 67 Synavive 67 Androxal ® 67 PRT# 67 nalbuphine ER 67 Panzem 66 orally bioavailable 66 VA# [002] 66 Panzem R 66 PSN# [002] 66 Naproxcinod 66 BZL# 66 Relivar 66 bremelanotide 66 Civacir 66 R#/MEM # 66 NP2 Enkephalin 65 torezolid phosphate 65 avanafil 65 IMA# 65 cannabinor 65 Bicifadine 65 Mipomersen 65 LibiGel ® 65 Pimavanserin 65 liprotamase 65 Plicera 65 Triolex 65 TOCOSOL Paclitaxel 65 Nasulin 65 faropenem medoxomil 65 DDP# 65 inhaled formulation 65 Dasatinib 65 liposomal formulation 65 IND submission 65 Rasagiline 65 Zoraxel 65 CR# vcMMAE 65 SILENOR TM 64 QNEXA 64 ospemifene 64 Elagolix 64 KRN# 64 oral rivaroxaban 64 Archexin 64 selective modulator 64 NEBIDO 64 GFT# 64 TBC# 64 diabetic neuropathic pain 64 Plenaxis TM 64 teriflunomide 64 lucinactant 64 TRO# 64 SILENOR 64 YONDELIS 64 CoFactor 64 anticancer compound 64 Tyrima 64 ANAVEX #-# [003] 64 oral formulation 64 Traficet EN 64 guanfacine extended release 64 GLYX 64 tasimelteon 64 ThGRF 64 Capesaris 64 RSD# 64 GLP toxicology studies 64 IRX 2 64 Amigal 64 Dalbavancin 63 Octreotide 63 mGluR5 NAM 63 Panzem R NCD 63 Ophena TM 63 EndoTAG TM -1 63 Laquinimod 63 PREOS 63 SERMs 63 INCB# [001] 63 lomitapide 63 Fx #A 63 pomalidomide 63 indibulin 63 alagebrium 63 vilazodone 63 generation purine nucleoside 63 Apoptone 63 Phase 2a trial 63 MAP# 63 ProSavin 63 Afresa 63 Linjeta TM 63 elotuzumab 63 alvimopan 63 targeted radiotherapeutic 63 ganetespib 63 DXL# 63 eltrombopag 63 Silodosin 63 faropenem 63 favorable pharmacokinetic profile 63 selective androgen receptor modulator 63 CCX# 63 Inhalation Solution 63 teduglutide 63 otelixizumab 63 phase IIb 63 Cardio Vascu Grow 63 ATL/TV# 63 BAL# [002] 63 midstage trials 63 methylnaltrexone 63 BNC# 63 Phase 2a clinical trials 63 Anthim 63 Zerenex 63 ganaxolone 63 Tasimelteon 63 Technosphere Insulin 63 Prosaptide 63 atacicept 63 Zelrix 63 CRMD# 63 #D#C# 63 ATL# [002] 63 Androxal TM 63 Lu AA# 63 ATL# [001] 63 INT# [002] 63 ALGRX 63 Anidulafungin 63 vidofludimus 62 Fodosine 62 TriRima 62 incyclinide 62 HuLuc# 62 forodesine 62 SparVax TM 62 thrombin inhibitor 62 CCR9 antagonist 62 metaglidasen 62 JZP 62 OncoVEX GM CSF 62 HQK 62 SinuNase ™ 62 novel prodrug 62 integrase inhibitor 62 HuMax CD4 62 Maribavir 62 adipiplon 62 Tesetaxel 62 Nebido 62 Ketotransdel 62 LY# [003] 62 riociguat 62 reslizumab 62 Vaprisol 62 RhuDex ® 62 rhIGF-I/rhIGFBP-3 62 Rezular 62 pharmacokinetic studies 62 thymalfasin 62 #ME# 62 Vilazodone 62 davalintide 62 OMNARIS HFA 62 omiganan 62 velafermin 62 HuMax EGFr 62 uric acid lowering 62 MAXY G# 62 ICA # 62 Silenor ® 62 GnRH antagonist 62 Tezampanel 62 BEMA Granisetron 62 Guanilib 62 Avanafil 62 bortezomib Velcade 62 Neurodex 62 AZILECT R 62 Surfaxin LS 62 AZILECT ® 62 Alzhemed TM 62 investigational compound 62 Solulin 62 alvespimycin 62 rEV# 62 tezampanel NGX# 62 rhThrombin 62 pegloticase 62 zileuton CR 62 PCK# 62 PEG SN# 62 LHRH antagonist 62 novel histone deacetylase 62 basal insulin analogue 62 Quinamed 62 Serdolect ® 62 orBec 62 Anturol TM 62 VAPRISOL 62 Cetrorelix 62 OMAPRO 62 PNP inhibitor 62 Phase IIB 62 SNRI 62 Phenoptin 62 ulimorelin 62 sitaxsentan 62 CDP# 62 Vimpat R 62 intranasal formulation 62 orally dosed 62 NGX# 62 investigational humanized monoclonal antibody 62 CORT # 62 Zingo TM 62 Myocet 62 preclinically 62 Anturol ® 62 GSK# [002] 62 URG# 62 anidulafungin 62 Relovair 62 Sym# 62 Fibrillex 62 Reverset 62 Chemophase 62 Azedra 62 Aerosurf 62 ISIS # 62 Corlux 62 ApoB SNALP 62 CBLC# 61 pralatrexate 61 bicifadine 61 balsalazide tablet 61 Valdoxan 61 GALNS 61 AeroLEF TM 61 Ambrisentan 61 phase IIa 61 Desmoteplase 61 HuMax CD# 61 SNT MC# 61 MYDICAR 61 dextofisopam 61 Cethromycin 61 elagolix 61 Stedivaze 61 Phase Ib study 61 NPSP# 61 phase Ib 61 Anavex #-# 61 octreotide acetate 61 OXi# 61 Talabostat 61 Thiovir 61 KNS # 61 Dyloject TM 61 Lofexidine 61 Phase 2b study 61 Omigard 61 Personalized Immunotherapy 61 MAGE A3 ASCI 61 tanespimycin 61 VALSTAR 61 Ruconest 61 aleglitazar 61 Spiegelmer ® 61 ISTODAX 61 talactoferrin 61 Tarceva TM 61 APF# 61 oral methylnaltrexone 61 Ganciclovir 61 Aganocide 61 NEUMUNE 61 PRTX 61 QNEXA ® 61 Dapagliflozin 61 Icatibant 61 histamine dihydrochloride 61 subcutaneously administered 61 CB2 selective receptor agonist 61 BLA filing 61 OvaRex R 61 receptor tyrosine kinase inhibitor 61 Dabigatran etexilate 61 RECOTHROM R 61 Phase IIb trials 61 prucalopride 61 Qutenza TM 61 desvenlafaxine 61 EMBEDA ™ 61 Zybrestat 61 erlotinib Tarceva 61 arbaclofen 61 polymerase inhibitor 61 antisense drug 61 Onconase 61 bazedoxifene 61 Azedra TM 61 FluCide 61 lasofoxifene 61 Angiocept 61 Xinlay 61 IV APAP 61 Pafuramidine 61 GLPG# 61 injectable formulation 61 Ferumoxytol 61 Hsp# inhibitor 61 RhuDex 61 ARIKACE ™ 61 tiapamil 61 Actemra tocilizumab 61 pharmacodynamic properties 61 Trexima 61 phase IIb clinical 61 Romiplostim 61 mTOR inhibitor 61 Phase #b/#a 61 JAK inhibitor 61 histone deacetylase inhibitor 61 Phase IIb clinical trials 61 Nanobody ® 61 depsipeptide 61 Serdaxin 61 rFIXFc 61 NasalFent 61 pharmacologically active 61 Phase #b/#a trial 61 phase IIa clinical 61 oral salmon calcitonin 61 HCV protease 61 sulodexide 61 OHR/AVR# 61 Factor VIIa 61 Troxatyl 61 5 HT6 receptor 61 AAG geldanamycin analog 61 iloperidone 61 therapeutic monoclonal antibody 61 PSN# [001] 61 Bevirimat 61 Zavesca R 61 Vidofludimus 61 Prodarsan ® 61 immunomodulator 60 Duromist ™ 60 immune modulating 60 alogliptin 60 Cannabinor 60 Xanafide 60 Protexia R 60 HGS# 60 Ophena 60 generation antisense 60 Zemiva TM 60 TAFA# 60 pharmacokinetic PK study 60 THR beta agonist 60 registrational trial 60 GTC recombinant human 60 Aptivus ® 60 RNAi therapeutic targeting PCSK9 60 caspofungin 60 ASONEP 60 TYZEKA 60 Kahalalide F 60 cangrelor 60 TRIOLEX 60 Frova ® 60 GAP #B# 60 Gabapentin GR 60 anti amnesic 60 anticancer agent 60 vemurafenib 60 Degarelix 60 CaPre TM 60 Phase 1a clinical 60 Pruvel 60 PEG PAL 60 Diamyd R 60 Lixivaptan 60 immunotherapeutic vaccine 60 midstage clinical 60 Androxal 60 obatoclax 60 candidate REP# 60 Excellagen 60 ponatinib 60 PLK1 SNALP 60 proteasome inhibitor 60 Vernakalant 60 immune modulatory 60 TLK# 60 Factor Xa inhibitor 60 pan HDAC inhibitor 60 SERCA2a 60 Milnacipran 60 ONTAK 60 calcitonin 60 NVA# 60 cetrorelix 60 TG# [003] 60 Trofex 60 phase IIb trial 60 radiation sensitizer 60 ATPace TM 60 Elesclomol 60 IIa trial 60 maximally tolerated dose 60 KAPVAY ™ 60 preclinical toxicology 60 Allovectin 7 60 ABILIFY ® 60 TELINTRA 60 ELND# 60 brivaracetam 60 injectable formulations 60 Lacosamide 60 HCV protease inhibitor 60 Phase 1b trial 60 ZOLINZA 60 dalbavancin 60 pseudobulbar affect PBA 60 Muraglitazar 60 TPI ASM8 60 Mycamine 60 DAVANAT R 60 cathepsin K inhibitor 60 LEVADEX TM 60 AP# [003] 60 glucokinase activator 60 lapatinib Tykerb 60 epothilone 60 inhaled liposomal ciprofloxacin 60 intravenous acetaminophen 60 RDEA# 60 tocilizumab 60 recombinant biopharmaceutical 60 pitavastatin 60 mertansine 60 Inhalation Powder 60 intranasal delivery 60 Nanobody 60 CBLB# 60 orally administered 60 EVIZON TM 60 BEMA TM Fentanyl 60 desvenlafaxine succinate 60 Acetavance 60 SRT# [003] 60 Egrifta 60 MoxDuo IR 60 PEGPH# 60 FIRMAGON R 60 ALN VSP 60 AEGR 60 investigational antiplatelet agent 60 EOquin TM 60 pertuzumab 60 Cinryze ™ 60 PRX # 60 MGCD# [001] 60 Ixempra 60 histone deacetylase HDAC inhibitor 60 AeroLEF 60 romidepsin novel 60 Onrigin 60 systemically administered 60 Oxytrex 60 urocortin 2 60 candidate deforolimus 60 ELACYT 60 TOCOSOL Camptothecin 60 CRD5 60 NOX E# 60 neuroprotective properties 60 ONCONASE R 60 BCX# 60 CXB# 60 RSD# oral 60 Symadex 60 peripherally acting 60 EXALGO 60 Atiprimod 60 afamelanotide 60 Genz # 60 NDA resubmission 60 ILUVIEN ® 60 Mirapexin 60 Q#IR 60 Acetavance TM 60 Formoterol 60 preclinical efficacy 60 DP b# 60 ALVESCO HFA 60 Oral NKTR 60 Chrysalin 60 DermaVir Patch 60 ALN PCS 60 Zenvia ™ 60 FENTORA 60 Phase 2a clinical 60 anti leukemic 60 BENLYSTA ® 60 DPP4 60 CEQ# 60 MYDICAR ® 60 Firazyr 60 Ceflatonin 60 EndoTAG TM 60 HCV protease inhibitors 60 antiplatelet agent 60 Carfilzomib 60 oral antiviral 60 PEG Interferon lambda 60 OncoGel 60 Tracleer R 60 Excellarate 60 Ventavis ® 60 NUVIGIL 60 Aflibercept 60 intravenously administered 60 oxaliplatin Eloxatin 60 Pirfenidone 60 GRNVAC1 60 alefacept 60 Aquinox 60 MDV# 60 Fortical R 60 Calcitonin 60 diarrhea predominant irritable 60 tramiprosate 60 chemopreventive agent 60 Diamyd ® 60 PTH #-# 60 Elocalcitol 60 Memryte 60 vorinostat 60 NV1FGF 60 PREOS R 60 CCR5 inhibitor 60 Ramoplanin 60 posaconazole 60 vosaroxin 60 oral anticancer 60 ALN TTR 60 trodusquemine 60 Voraxaze 60 sapacitabine 60 HDL Mimetic Peptide 60 LibiGel 59 CRx 59 refractory gout 59 TOLAMBA 59 QLT# 59 highly selective inhibitor 59 BIM #A# 59 selective estrogen receptor modulator 59 investigational drug 59 angiogenesis inhibitor 59 CCR5 antagonist 59 XOMA 3AB 59 glucagon receptor 59 ixabepilone 59 preclinical pharmacokinetic 59 FM VP4 59 casopitant 59 Emselex 59 Hycamtin 59 HGS ETR2 59 Interferon alpha 59 PTH1 59 HspE7 59 injectable investigational 59 Proellex TM 59 teplizumab 59 pregabalin Lyrica 59 omacetaxine mepesuccinate 59 5 HT3 antagonist 59 DAVANAT 59 non nucleoside inhibitor 59 immunomodulatory 59 systemic RNAi 59 Aviptadil 59 Crofelemer 59 DB# [003] 59 eprotirome 59 topical formulation 59 Aplidin 59 OvaRex ® MAb 59 REG1 59 albiglutide 59 oral anticoagulant 59 ALN TTR# 59 EGS# 59 pramlintide 59 Neuradiab 59 Amplimexon 59 Trofex TM 59 anti androgen 59 JAK2 inhibitor 59 targeting CD# 59 Asentar 59 VitiGam 59 synthetic siRNA 59 PS# [001] 59 Abiraterone 59 Linjeta ™ 59 Velac 59 Abiraterone acetate 59 postoperative ileus 59 Indiplon 59 droxidopa 59 goserelin 59 OncoVEX 59 Annamycin 59 ibandronate 59 Rebif ® 59 Iloperidone 59 Alpharadin 59 CYC# 59 COREG CR 59 Flutiform TM 59 VivaGel TM 59 Onalta 59 Bifeprunox 59 Ereska 59 DU #b 59 Orazol 59 Exforge HCT 59 proteasome inhibitors 59 Tocosol Paclitaxel 59 LEVADEX 59 XmAb# 59 methylnaltrexone bromide 59 EvaMist TM 59 BioVant 59 Genasense ® oblimersen 59 GED aPC 59 MEK inhibitors 59 investigational pan BCR 59 OFIRMEV 59 H#N# VLP vaccine 59 SCH # 59 Nuvion 59 TOCOSOL 59 Preclinical studies suggest 59 torsemide ER 59 ZEGERID Capsules 59 SinuNase TM 59 tafamidis 59 AERx iDMS 59 mapatumumab 59 IAP inhibitors 59 Clonicel 59 vascular disrupting agents 59 zolpidem tartrate sublingual tablet 59 Insegia 59 ZYBRESTAT 59 nucleoside analog 59 vernakalant 59 Zalbin 59 Solzira 59 Amphotericin B 59 compound AEZS 59 Puricase 59 Prestara 59 pharmacological chaperone 59 granulated mesalamine 59 therapeutic peptide 59 Iluvien ® 59 Aurexis 59 Noxafil 59 ramelteon 59 Dextofisopam 59 ACAPODENE TM 59 M6G 59 Sanctura XR 59 Squalamine 59 Zensana 59 Benlysta belimumab 59 isoform selective 59 oxymorphone ER 59 hepatitis C protease inhibitor 59 dihydrochloride 59 alpha blocker 59 AEG# 59 dopamine receptor agonist 59 dextromethorphan hydrobromide 59 Protexia ® 59 Fentanyl TAIFUN R 59 orally inhaled 59 dexanabinol 59 pharmacokinetic PK 59 RGB # 59 NeuroSTAT ® 59 YONDELIS R 59 delafloxacin 59 biomodulator 59 ALKS 59 BioNumerik 59 oxybutynin gel 59 ESBA# 59 HSP# inhibitor 59 investigational oral 59 Rapaflo 59 CA4P 59 PROVENGE sipuleucel T 59 Junovan 59 GLP1 agonist 59 Adentri 59 Teriparatide 59 sorafenib Nexavar 59 RAPAFLO 59 ENMD # 59 Phase III Clinical Trials 59 triphendiol 59 IPLEX 59 Huntexil 59 crofelemer 59 FOLOTYN ® 59 CIMZIA TM 59 Chemokine 59 CG# [003] 59 CTAP# Capsules 59 nanoviricide 59 receptor inhibitor 59 Sulonex 59 xanthine oxidase inhibitor 59 dermal patch 59 docetaxel Taxotere R 59 Histalean 59 Ozarelix 59 ZEVALIN ® 59 SPC# [001] 59 Granulocyte Colony Stimulating Factor 59 L BLP# 59 GSK# [001] 59 Restanza 59 NN# [001] 59 Onsolis 59 Opterone 59 alkylating agent 59 AcelRx 59 Romidepsin 59 atrasentan 59 evaluating tivozanib 59 STEDESA 59 2 methoxyestradiol 59 Febuxostat 59 AVE# 59 sorafenib tablets 59 antitussive 59 neuraminidase inhibitor 59 Onbrez Breezhaler 59 Zolinza 59 Phase IIa clinical 59 Phase 2b clinical trials 59 Toremifene 59 Soriatane 59 PrevOnco 59 investigational monoclonal antibody 59 MEK inhibitor 59 insulin sensitizer 59 SMT C# 59 MAb 59 Cancidas 59 RLY# 59 efficacy tolerability 59 trospium 59 lintuzumab 59 FTY# fingolimod 59 efficacious 59 Marqibo 59 Luramist 59 PROCHYMAL 59 Phase IIa trial 59 aclidinium bromide 59 dose escalation Phase 59 CIMZIA ™ 59 Enkephalin 59 fosbretabulin 59 Phase IIb trial 59 MEK inhibitor RDEA# 59 bardoxolone methyl 59 JAK inhibitors 58 zolmitriptan 58 EOquin 58 HGS ETR1 58 Exherin TM 58 Lysteda 58 Triapine R 58 Pagoclone 58 CERVARIX 58 KRYSTEXXA TM pegloticase 58 Elacytarabine 58 TKM ApoB 58 CYT# QbG# 58 visilizumab 58 plasma kallikrein inhibitor 58 TRV# [001] 58 ZOMIG 58 triglyceride lowering 58 subcutaneous SC 58 Polymer Microspheres 58 VPRIV 58 Alvesco R 58 Revlimid lenalidomide 58 autologous cellular immunotherapy 58 Cloretazine 58 CINQUIL 58 antithrombotic 58 MyVax 58 Viramidine 58 Aclidinium 58 partial agonist 58 IL# PE#QQR 58 Cleviprex TM clevidipine 58 inhibit metastasis 58 Zosano 58 Cloretazine ® 58 SLx 58 LymphoStat B TM 58 Perforomist ™ Inhalation Solution 58 CRLX# 58 Tamibarotene 58 IMiDs R 58 custirsen 58 E2F Decoy 58 apremilast 58 Telavancin 58 voreloxin 58 Krystexxa 58 CB2 selective 58 Bicalutamide 58 DPX Survivac 58 Liraglutide 58 enzastaurin 58 transmucosal delivery system 58 T Pred 58 Anturol 58 LEP ETU 58 brostallicin 58 Safinamide 58 defensin mimetic antibiotic 58 Aurora kinase inhibitor 58 Clevudine 58 overactive bladder AA# 58 tecarfarin 58 Lamictal ODT 58 Eli Lilly Cymbalta 58 dorzolamide 58 intranasal insulin 58 Amrubicin 58 Auxilium transmucosal film 58 antitumor effects 58 topical formulations 58 Linjeta 58 Bendavia 58 ruxolitinib 58 ozarelix 58 epigenetic therapies 58 systemic RNAi therapeutic 58 registrational 58 LT NS# 58 APD# 58 Somatuline R Autogel R 58 Zelapar 58 tesetaxel 58 molecular entities NMEs 58 panitumumab Vectibix 58 inecalcitol 58 pharmacokinetic profile 58 6R BH4 58 ITAX 58 DepoDur TM 58 TREDAPTIVE 58 HCD# [002] 58 renin inhibitor 58 Tolvaptan 58 Neulasta ® 58 itraconazole 58 BAY #-# 58 Intuniv 58 IAP inhibitor 58 Bortezomib 58 C2L 58 PD LID 58 GRN# 58 Exalgo 58 PHX# 58 vaginally administered lidocaine 58 Lodotra 58 azilsartan medoxomil 58 Novolimus 58 luliconazole 58 ATD Gel 58 INKP 58 tolerability profile 58 omacetaxine 58 ADX# 58 IND enabling 58 pexiganan 58 Nestorone 58 Itopride 58 thetreatment 58 fluoroquinolone antibiotic 58 Perforomist TM Inhalation Solution 58 Altastaph 58 Ramelteon 58 mecamylamine 58 mesylate 58 transdermal gel 58 ONCONASE 58 optimal dosing 58 Alferon N 58 Ceplene TM 58 palonosetron 58 Targretin 58 ocrelizumab 58 Luteinizing Hormone Releasing Hormone 58 epothilones 58 cMET 58 rALLy trial 58 EnzymeRx 58 AMMONUL R sodium phenylacetate 58 inhibitor PPI 58 solithromycin 58 Fablyn 58 silodosin 58 Clolar ® 58 rNAPc2 58 octreotide 58 nasal formulation 58 topical ophthalmic 58 Exenatide LAR 58 subcutaneous formulation 58 Aganocide ® 58 bevirimat 58 olaparib 58 valopicitabine 58 glatiramer 58 torezolid 58 postapproval 58 KSP inhibitor 58 USL# 58 Indaflex TM 58 MNTX 58 OX1 58 novel peptide 58 lead Aganocide compound 58 SUTENT ® 58 HFA MDI 58 Phase Ia 58 GAMMAGARD 58 TNF alpha inhibitor 58 ARRY # 58 tesofensine 58 Telintra 58 Azilect ® 58 Emezine 58 PRISTIQ 58 muraglitazar 58 Gaboxadol 58 ACAPODENE 58 CANCIDAS 58 insulin analogs 58 bardoxolone 58 OMS#HP 58 Darusentan 58 DCCR 58 MTP inhibitor 58 Adlea 58 clinical trials 58 Proquin XR 58 Darinaparsin 58 radezolid 58 Posiphen 58 trastuzumab DM1 T DM1 58 oral taxane 58 trastuzumab DM1 58 ORENCIA R 58 MAXY VII 58 treat dysmenorrhea 58 MEVACOR 58 Panzem NCD